Djordje Musil
Frankfurter Str. 250
Darmstadt, HE 64293, Germany
Darmstadt, HE 64293, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Discovery of ART5537: A Potent and Selective Small-Molecule Probe for EXO1.
Journal: Journal of medicinal chemistry
Published: December 08, 2025
Phenotypic Hit Identification and Optimization of Novel Pan-TEAD and Subtype-Selective Inhibitors.
Journal: Journal of medicinal chemistry
Published: November 10, 2025
Phenotypic Hit Identification and Optimization of Novel Pan-TEAD and Subtype-Selective Inhibitors.
Journal: Journal of medicinal chemistry
Published: November 10, 2025
Pushing the limits of hydrogen/deuterium exchange mass spectrometry to study protein:fragment low affinity interactions.
Journal: Communications chemistry
Published: October 03, 2025
MoA Studies of the TEAD P-Site Binding Ligand MSC-4106 and Its Optimization to TEAD1-Selective Amide M3686.
Journal: Journal of medicinal chemistry
Published: December 20, 2024
Discovery of reversible and covalent TEAD 1 selective inhibitors MSC-1254 and MSC-5046 based on one scaffold.
Journal: Bioorganic & medicinal chemistry letters
Published: July 21, 2024
On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality.
Journal: Protein science : a publication of the Protein Society
Published: July 04, 2024
Discovery of Cycloalkyl[c]thiophenes as Novel Scaffolds for Hypoxia-Inducible Factor-2α Inhibitors.
Journal: Journal of medicinal chemistry
Published: July 05, 2023
Discovery of quinazoline HPK1 inhibitors with high cellular potency.
Journal: Bioorganic & medicinal chemistry
Published: February 23, 2023
Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression.
Journal: ACS medicinal chemistry letters
Published: November 11, 2022
Optimization of TEAD P-Site Binding Fragment Hit into In Vivo Active Lead MSC-4106.
Journal: Journal of medicinal chemistry
Published: June 28, 2022
Optimization of a Screening Hit toward M2912, an Oral Tankyrase Inhibitor with Antitumor Activity in Colorectal Cancer Models.
Journal: Journal of medicinal chemistry
Published: July 13, 2021
Last Updated: 09/26/2026